Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing

Ana Homšek Ilić, Marija Jovanović, Srđan Marković, Sandra Vezmar Kovačević, Tamara Knežević Ivanovski, Đorđe Kralj, Petar Svorcan, Katarina Vučićević · 2026

Read Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing by Ana Homšek Ilić, Marija Jovanović, Srđan Marković, Sandra Vezmar Kovačević, Tamara Knežević Ivanovski, Đorđe Kralj, Petar Svorcan, Katarina Vučićević (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352967.txt.

Description

Homšek Ilić and colleagues, in a 2026 study, ask which ready-made dosing model best predicts blood levels of infliximab, a drug used for inflammatory bowel disease. Crohn's disease and ulcerative colitis differ in where and how deeply the gut is inflamed, and severe forms are harder to treat. A model that fits one group may miss in another.

The team tested twenty published models against drug monitoring data from their hospital, split into five groups: all patients, severe colitis flares, Crohn's disease, fistulizing Crohn's, and ulcerative colitis. No single model passed every accuracy test. Different models led for different groups, both when predicting cold and when updated with a patient's own past readings. Some simulation checks agreed, others pointed elsewhere. The authors conclude that clinics should pick the model by disease type and severity, a step toward dosing matched to the patient rather than one average recipe.

Catalog record

CREATORAna Homšek Ilić, Marija Jovanović, Srđan Marković, Sandra Vezmar Kovačević, Tamara Knežević Ivanovski, Đorđe Kralj, Petar Svorcan, Katarina Vučićević
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51822
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0352967

Browse the full library · About the Tower of Babel